Average Co-Inventor Count = 4.92
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Signal Pharmaceuticals, Inc. (10 from 169 patents)
2. Hoffmann-la Roche Inc. (3 from 4,942 patents)
3. Arrowhead Pharmaceuticals, Inc. (3 from 95 patents)
4. Other (1 from 832,680 patents)
5. Arrowhead Research Corporation (1 from 18 patents)
6. F. Hoffmann-la Roche Ag (168 patents)
18 patents:
1. 11920134 - Compositions and methods for inhibiting expression of RRM2 genes
2. 11590139 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
3. 10940152 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
4. 10646493 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
5. 10619160 - Compositions and methods for inhibiting expression of RRM2 genes
6. 10576085 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
7. 9938531 - Compositions and methods for inhibiting expression of RRM2 genes
8. 9795607 - Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
9. 9737541 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
10. 9623028 - Methods of treating a cancer using substituted pyrrolopyrimidine compounds, compositions thereof
11. 9512124 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
12. 9428509 - Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
13. 9346812 - Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
14. 8946176 - Compositions and methods for inhibiting expression of RRM2 genes
15. 8741889 - Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitor